Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,096
Closed -$205K 1407
2025
Q4
$205K Buy
+3,096
New +$200K 0.01% 968
2025
Q1
Sell
-4,435
Closed -$345K 640
2024
Q4
$345K Buy
+4,435
New +$328K 0.01% 400
2023
Q4
Sell
-48,708
Closed -$4.54M 353
2023
Q3
$4.54M Buy
+48,708
New +$5.49M 0.09% 59

Other funds holding DXCM

DRW Securities's DXCM Position: Q1 2026 in Review

DRW Securities sold out of DexCom (DXCM) in Q1 2026, closing a stake of 3,096 shares — an estimated $205K sold.

DRW Securities first reported a position in DXCM in Q3 2023 and held it in 3 quarters. The position peaked at $4.54M in Q3 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • DRW Securities reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 3,096 DexCom shares in Q1 2026, an estimated $205K.
  • DRW Securities first reported a position in DexCom in Q3 2023 and held it in 3 quarters.
  • DRW Securities's DexCom position peaked at $4.54M in Q3 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.